ヒアルロン酸市場 : 2027年までの予測

出版：Market Research Future（マーケットリサーチフューチャー）　出版年月：2023年4月

Hyaluronic acid market Forecast to 2027
ヒアルロン酸市場 : 2027年までの予測

レポート目次　　　　お問合せ・ご注文　　　　価格・納期について

Hyaluronic acid market Forecast to 2027
Market Overview
Increasing use of hyaluronic acid in cosmetic and personal care products, as well as an increase in the number of cosmetic surgeries. Hyaluronic acid is well known for its skin benefits such as reducing the appearance of fine lines, wrinkles, redness, and dermatitis. Hyaluronic acid aids in the retention of over 1,000 times its weight in water within skin cells, making it an excellent moisturiser. It promotes skin hydration and collagen production, combats free radicals, and maintains skin elasticity. It also functions as a humectant, a hygroscopic skincare ingredient that draws moisture from its surroundings. With consumer demand for anti-aging and multifunctional personal care products increasing, personal care product manufacturers are incorporating multi-functional and multiple ingredients into their products.

Segment Overview
The hyaluronic acid market is segmented based on grades, applications, end-users, and regions. The cosmetic grade segment accounted for the majority of the market revenue in 2021, due to its high demand as a cosmetic ingredient in personal care products. On the other hand, the pharmaceutical grade segment is the fastest-growing due to its use in treating various diseases and as a biomaterial. In terms of applications, the aesthetics segment dominated the market in 2021 due to consumer demand for minimally invasive cosmetic procedures. In terms of end-users, dermatology clinics held the largest market share in 2021 due to the use of hyaluronic acid-based fillers in skin treatments. North America had the largest market share in 2021, due to the presence of a large aging population and the growing demand for minimally invasive cosmetic surgeries.

Regional Analysis
Europe has the second-largest market share for hyaluronic acid due to rising aesthetic consciousness, rapid technological advancements, and shorter procedure times, among other factors driving the market in Europe. Furthermore, the German hyaluronic acid market held the largest market share, while the UK hyaluronic acid market was the fastest growing in the European region.
In the coming years, it is expected that the market for hyaluronic acid in the Asia-Pacific region will grow rapidly due to several factors such as growing unmet medical needs in developing economies, heightened knowledge of non-invasive procedures, and rising disposable income. Among the countries in the region, the China hyaluronic acid market currently holds the largest share, while the India hyaluronic acid market is growing at a rapid pace.

Major Players
Hyaluronic acid market is mainly dominated by Genzyme Corporation (US), Zimmer Biomet (US), Seikagaku Corporation (Japan), Hoffmann-La Roche Ag (Switzerland), Allergan (Ireland), Anika Therapeutics, Salix Pharmaceuticals (US), Sanofi (France), Inc. (US),Galderma Laboratories L.P. (US), and Smith & Nephew Plc (UK).
COVID 19 Impacts
The Covid-19 pandemic has had a significant impact on the global Hyaluronic Acid market. The initial spread of the virus caused many countries to impose lockdowns and restrictions on non-essential procedures, resulting in a slowdown in the demand for Hyaluronic Acid. This was particularly true in the cosmetic and aesthetic industry, where the use of Hyaluronic Acid is common. The halt of routine medical procedures and decreased consumer spending also contributed to a decrease in demand for Hyaluronic Acid.
However, as the pandemic has continued, the market has seen a gradual recovery as countries have started to lift restrictions and return to normal operations. In addition, the increased awareness of personal health and hygiene, as well as the need for medical procedures to treat the long-term effects of the virus, has led to a resurgence in demand for Hyaluronic Acid.

目次

TABLE OF CONTENT
LIST OF CONTENTS
1 EXECUTIVE SUMMARY 16
2 MARKET INTRODUCTION 18
2.1 SCOPE OF THE STUDY 18
2.2 RESEARCH OBJECTIVE 18
2.3 MARKET STRUCTURE 18
2.4 ASSUMPTIONS & LIMITATIONS 19
3 RESEARCH METHODOLOGY 20
3.1 DATA MINING 20
3.2 SECONDARY RESEARCH 21
3.3 PRIMARY RESEARCH 22
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 23
3.5 FORECASTING TECHNIQUES 24
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 25
3.6.1 BOTTOM-UP APPROACH 26
3.6.2 TOP-DOWN APPROACH 26
3.7 DATA TRIANGULATION 27
3.8 VALIDATION 27
4 MARKET DYNAMICS 28
4.1 INTRODUCTION 28
4.2 DRIVERS 29
4.2.1 INCREASING APPLICATION OF HYALURONIC ACID IN COSMETIC & PERSONAL CARE PRODUCTS 29
4.2.2 INCREASING NUMBER OF COSMETIC SURGERIES 31
4.2.3 EXTENSIVE USE OF HYALURONIC ACID IN THE TREATMENT OF OSTEOARTHRITIS AND DRY EYE 32
4.3 RESTRAINTS 33
4.3.1 AVAILABILITY OF SUBSTITUTES 33
4.4 OPPORTUNITY 34
4.4.1 EXTENSIVE R&D ASSOCIATED WITH HYALURONIC ACID 34
4.5 TREND 35
4.5.1 USE OF HYALURONIC ACID AS AN ANIMAL SUPPLEMENT 35
5 MARKET FACTOR ANALYSIS 36
5.1 SUPPLY CHAIN ANALYSIS 36
5.1.1 RAW MATERIAL SUPPLIERS 37
5.1.2 HYALURONIC ACID PRODUCERS 37
5.1.3 DISTRIBUTION & SALES CHANNEL 37
5.1.4 END USERS 38
5.2 PORTER’S FIVE FORCES MODEL 38
5.2.1 BARGAINING POWER OF SUPPLIERS 39
5.2.2 BARGAINING POWER OF BUYERS 39
5.2.3 THREAT OF NEW ENTRANTS 39
5.2.4 THREAT OF SUBSTITUTES 39
5.2.5 INTENSITY OF RIVALRY 39
5.3 COVID-19 IMPACT ANALYSIS 40
5.3.1 IMPACT ON GROWTH RATE 40
5.3.2 IMPACT ON MAJOR PLAYERS 40
5.3.3 IMPACT ON PREFERENCE OF CUSTOMERS 40
5.3.4 IMPACT ON AESTHETIC INDUSTRY 42
6 GLOBAL HYALURONIC ACID MARKET, BY GRADE 43
6.1 OVERVIEW 43
6.2 COSMETIC GRADE 45
6.3 PHARMACEUTICAL GRADE 46
6.4 FOOD GRADE 47
7 GLOBAL HYALURONIC ACID MARKET, BY APPLICATION 48
7.1 OVERVIEW 48
7.2 AESTHETICS 49
7.3 OSTEOARTHRITIS 50
7.4 PHARMACEUTICAL API 51
7.5 COSMETICS 52
7.6 DIETARY SUPPLEMENTS 53
7.7 OPHTHALMOLOGY 54
7.8 OTHERS 54
8 GLOBAL HYALURONIC ACID MARKET, BY END USER 56
8.1 OVERVIEW 56
8.2 PHARMACEUTICAL INDUSTRY 58
8.3 DERMATOLOGY CLINICS & COSMETIC SURGERY CENTERS 59
8.4 FOOD INDUSTRY 60
8.5 PERSONAL CARE 61
8.6 OTHERS 61
9 GLOBAL HYALURONIC ACID MARKET, BY REGION 63
9.1 OVERVIEW 63
9.2 NORTH AMERICA 65
9.2.1 US 67
9.2.2 CANADA 69
9.3 EUROPE 71
9.3.1 FRANCE 74
9.3.2 GERMANY 75
9.3.3 UK 77
9.3.4 SPAIN 78
9.3.5 ITALY 80
9.3.6 RUSSIA 81
9.3.7 BELGIUM 83
9.3.8 POLAND 84
9.3.9 REST OF EUROPE 86
9.4 ASIA-PACIFIC 88
9.4.1 CHINA 91
9.4.2 JAPAN 92
9.4.3 INDIA 94
9.4.4 SOUTH KOREA 95
9.4.5 AUSTRALIA 97
9.4.6 THAILAND 98
9.4.7 INDONESIA 100
9.4.8 REST OF ASIA-PACIFIC 101
9.5 LATIN AMERICA 103
9.5.1 BRAZIL 105
9.5.2 MEXICO 107
9.5.3 ARGENTINA 108
9.5.4 REST OF LATIN AMERICA 110
9.6 MIDDLE EAST & AFRICA 112
9.6.1 SAUDI ARABIA 115
9.6.2 UAE 116
9.6.3 TURKEY 118
9.6.4 SOUTH AFRICA 119
9.6.5 ISRAEL 121
9.6.6 REST OF THE MIDDLE EAST &AFRICA 122
10 COMPETITIVE LANDSCAPE 124
10.1 OVERVIEW 124
10.2 COMPETITIVE BENCHMARKING 125
10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL HYALURONIC ACID MARKET 127
10.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 128
10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES 129
10.5.1 JOINT VENTURES & AGREEMENTS 130
10.5.2 MARKETING STRATEGY 130
10.5.3 MERGERS&ACQUISITIONS 130
10.6 FINANCIAL MATRIX 131
11 COMPANY PROFILES 132
11.1 ALLERGAN PLC 132
11.1.1 COMPANY OVERVIEW 132
11.1.2 FINANCIAL OVERVIEW 133
11.1.3 PRODUCTS/SERVICES OFFERED 133
11.1.4 KEY DEVELOPMENTS 134
11.1.5 SWOT ANALYSIS 134
11.1.6 KEY STRATEGIES 135
11.2 CONTIPRO AS. 136
11.2.1 COMPANY OVERVIEW 136
11.2.2 FINANCIAL OVERVIEW 136
11.2.3 PRODUCTS OFFERED 136
11.2.4 KEY DEVELOPMENTS 137
11.2.5 SWOT ANALYSIS 137
11.2.6 KEY STRATEGIES 137
11.3 SYMATESE 138
11.3.1 COMPANY OVERVIEW 138
11.3.2 FINANCIAL OVERVIEW 138
11.3.3 PRODUCTS OFFERED 138
11.3.4 KEY DEVELOPMENTS 138
11.3.5 SWOT ANALYSIS 139
11.3.6 KEY STRATEGIES 139
11.4 ZHONGLAN INDUSTRY CO., LTD. 140
11.4.1 COMPANY OVERVIEW 140
11.4.2 FINANCIAL OVERVIEW 140
11.4.3 PRODUCTS OFFERED 140
11.4.4 KEY DEVELOPMENTS 140
11.4.5 SWOT ANALYSIS 141
11.4.6 KEY STRATEGIES 141
11.5 ALTERGON ITALIA SRL 142
11.5.1 COMPANY OVERVIEW 142
11.5.2 FINANCIAL OVERVIEW 142
11.5.3 PRODUCTS OFFERED 142
11.5.4 KEY DEVELOPMENTS 142
11.5.5 SWOT ANALYSIS 143
11.5.6 KEY STRATEGIES 143
11.6 FIDIA FARMACEUTICI S.P.A. 144
11.6.1 COMPANY OVERVIEW 144
11.6.2 FINANCIAL OVERVIEW 144
11.6.3 PRODUCTS OFFERED 144
11.6.4 KEY DEVELOPMENTS 144
11.6.5 SWOT ANALYSIS 145
11.6.6 KEY STRATEGIES 145
11.7 BIOIBERICA SAU. 146
11.7.1 COMPANY OVERVIEW 146
11.7.2 FINANCIAL OVERVIEW 146
11.7.3 PRODUCTS OFFERED 146
11.7.4 KEY DEVELOPMENTS 146
11.7.5 SWOT ANALYSIS 147
11.7.6 KEY STRATEGIES 147
11.8 KEWPIE CORPORATION 148
11.8.1 COMPANY OVERVIEW 148
11.8.2 FINANCIAL OVERVIEW 148
11.8.3 PRODUCTS OFFERED 149
11.8.4 KEY DEVELOPMENTS 149
11.8.5 SWOT ANALYSIS 150
11.8.6 KEY STRATEGIES 150
11.9 SEIKAGAKU CORPORATION 151
11.9.1 COMPANY OVERVIEW 151
11.9.2 FINANCIAL OVERVIEW 152
11.9.3 PRODUCTS OFFERED 153
11.9.4 KEY DEVELOPMENTS 153
11.9.5 SWOT ANALYSIS 154
11.9.6 KEY STRATEGIES 154
11.10 ANIKA THERAPEUTICS 155
11.10.1 COMPANY OVERVIEW 155
11.10.2 FINANCIAL OVERVIEW 156
11.10.3 PRODUCTS/SERVICES OFFERED 157
11.10.4 KEY DEVELOPMENTS 157
11.10.5 SWOT ANALYSIS 158
11.10.6 KEY STRATEGIES 158
12 APPENDIX 159
12.1 REFERENCES 159
12.2 RELATED REPORTS 160

LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 19
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 22
TABLE 3 GLOBAL HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 44
TABLE 4 GLOBAL HYALURONIC ACID MARKET FOR COSMETIC GRADE, BY REGION, 2018–2027 (USD MILLION) 45
TABLE 5 GLOBAL HYALURONIC ACID MARKET FOR PHARMACEUTICAL GRADE, BY REGION, 2018–2027 (USD MILLION) 46
TABLE 6 GLOBAL HYALURONIC ACID MARKET FOR FOOD-GRADE, BY REGION, 2018–2027 (USD MILLION) 47
TABLE 7 GLOBAL HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 49
TABLE 8 GLOBAL HYALURONIC ACID MARKET FOR AESTHETICS, BY REGION, 2018–2027 (USD MILLION) 49
TABLE 9 GLOBAL HYALURONIC ACID MARKET FOR OSTEOARTHRITIS, BY REGION, 2018–2027 (USD MILLION) 50
TABLE 10 GLOBAL HYALURONIC ACID MARKET FOR PHARMACEUTICAL API, BY REGION, 2018–2027 (USD MILLION) 51
TABLE 11 GLOBAL HYALURONIC ACID MARKET FOR COSMETICS, BY REGION, 2018–2027 (USD MILLION) 52
TABLE 12 GLOBAL HYALURONIC ACID MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2018–2027 (USD MILLION) 53
TABLE 13 GLOBAL HYALURONIC ACID MARKET FOR OPHTHALMOLOGY, BY REGION, 2018–2027 (USD MILLION) 54
TABLE 14 GLOBAL HYALURONIC ACID MARKET, BY OPHTHALMOLOGY, FOR TYPE, 2018–2027 (USD MILLION) 54
TABLE 15 GLOBAL HYALURONIC ACID MARKET FOR OTHERS, BY REGION, 2018–2027 (USD MILLION) 55
TABLE 16 GLOBAL HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 57
TABLE 17 GLOBAL HYALURONIC ACID MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2018–2027 (USD MILLION) 58
TABLE 18 GLOBAL HYALURONIC ACID MARKET FOR DERMATOLOGY CLINICS & COSMETIC SURGERY CENTERS, BY REGION, 2018–2027 (USD MILLION) 59
TABLE 19 GLOBAL HYALURONIC ACID MARKET FOR FOOD INDUSTRY, BY REGION, 2018–2027 (USD MILLION) 60
TABLE 20 GLOBAL HYALURONIC ACID MARKET FOR PERSONAL CARE, BY REGION, 2018–2027 (USD MILLION) 61
TABLE 21 GLOBAL HYALURONIC ACID MARKET FOR OTHERS, BY REGION, 2018–2027 (USD MILLION) 61
TABLE 22 GLOBAL HYALURONIC ACID MARKET, BY REGION, 2018–2027 (USD MILLION) 64
TABLE 23 NORTH AMERICA: HYALURONIC ACID MARKET, BY COUNTRY, 2018–2027 (USD MILLION) 65
TABLE 24 NORTH AMERICA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 66
TABLE 25 NORTH AMERICA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 66
TABLE 26 NORTH AMERICA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 67
TABLE 27 US: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 67
TABLE 28 US: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 68
TABLE 29 US: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 68
TABLE 30 CANADA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 69
TABLE 31 CANADA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 69
TABLE 32 CANADA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 70
TABLE 33 EUROPE: HYALURONIC ACID MARKET, BY COUNTRY, 2018–2027 (USD MILLION) 72
TABLE 34 EUROPE: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 72
TABLE 35 EUROPE: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 73
TABLE 36 EUROPE: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 73
TABLE 37 FRANCE: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 74
TABLE 38 FRANCE: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 74
TABLE 39 FRANCE: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 75
TABLE 40 GERMANY: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 75
TABLE 41 GERMANY: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 76
TABLE 42 GERMANY: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 76
TABLE 43 UK: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 77
TABLE 44 UK: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 77
TABLE 45 UK: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 78
TABLE 46 SPAIN: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 78
TABLE 47 SPAIN: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 79
TABLE 48 SPAIN: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 79
TABLE 49 ITALY: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 80
TABLE 50 ITALY: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 80
TABLE 51 ITALY: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 81
TABLE 52 RUSSIA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 81
TABLE 53 RUSSIA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 82
TABLE 54 RUSSIA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 82
TABLE 55 BELGIUM: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 83
TABLE 56 BELGIUM: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 83
TABLE 57 BELGIUM: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 84
TABLE 58 POLAND: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 84
TABLE 59 POLAND: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 85
TABLE 60 POLAND: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 85
TABLE 61 REST OF EUROPE: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 86
TABLE 62 REST OF EUROPE: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 86
TABLE 63 REST OF EUROPE: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 87
TABLE 64 ASIA-PACIFIC: HYALURONIC ACID MARKET, BY COUNTRY, 2018–2027 (USD MILLION) 89
TABLE 65 ASIA-PACIFIC: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 89
TABLE 66 ASIA-PACIFIC: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 90
TABLE 67 ASIA-PACIFIC: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 90
TABLE 68 CHINA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 91
TABLE 69 CHINA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 91
TABLE 70 CHINA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 92
TABLE 71 JAPAN: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 92
TABLE 72 JAPAN: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 93
TABLE 73 JAPAN: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 93
TABLE 74 INDIA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 94
TABLE 75 INDIA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 94
TABLE 76 INDIA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 95
TABLE 77 SOUTH KOREA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 95
TABLE 78 SOUTH KOREA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 96
TABLE 79 SOUTH KOREA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 96
TABLE 80 AUSTRALIA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 97
TABLE 81 AUSTRALIA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 97
TABLE 82 AUSTRALIA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 98
TABLE 83 THAILAND: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 98
TABLE 84 THAILAND: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 99
TABLE 85 THAILAND: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 99
TABLE 86 INDONESIA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 100
TABLE 87 INDONESIA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 100
TABLE 88 INDONESIA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 101
TABLE 89 REST OF ASIA-PACIFIC: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 101
TABLE 90 REST OF ASIA-PACIFIC: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 102
TABLE 91 REST OF ASIA-PACIFIC: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 102
TABLE 92 LATIN AMERICA: HYALURONIC ACID MARKET, BY COUNTRY, 2018–2027 (USD MILLION) 104
TABLE 93 LATIN AMERICA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 104
TABLE 94 LATIN AMERICA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 104
TABLE 95 LATIN AMERICA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 105
TABLE 96 BRAZIL: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 105
TABLE 97 BRAZIL: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 106
TABLE 98 BRAZIL: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 106
TABLE 99 MEXICO: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 107
TABLE 100 MEXICO: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 107
TABLE 101 MEXICO: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 108
TABLE 102 ARGENTINA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 108
TABLE 103 ARGENTINA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 109
TABLE 104 ARGENTINA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 109
TABLE 105 REST OF LATIN AMERICA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 110
TABLE 106 REST OF LATIN AMERICA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 110
TABLE 107 REST OF LATIN AMERICA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 111
TABLE 108 MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY COUNTRY, 2018–2027 (USD MILLION) 113
TABLE 109 MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 113
TABLE 110 MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 114
TABLE 111 MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 114
TABLE 112 SAUDI ARABIA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 115
TABLE 113 SAUDI ARABIA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 115
TABLE 114 SAUDI ARABIA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 116
TABLE 115 UAE: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 116
TABLE 116 UAE: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 117
TABLE 117 UAE: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 117
TABLE 118 TURKEY: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 118
TABLE 119 TURKEY: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 118
TABLE 120 TURKEY: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 119
TABLE 121 SOUTH AFRICA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 119
TABLE 122 SOUTH AFRICA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 120
TABLE 123 SOUTH AFRICA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 120
TABLE 124 ISRAEL: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 121
TABLE 125 ISRAEL: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 121
TABLE 126 ISRAEL: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 122
TABLE 127 REST OF THE MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 122
TABLE 128 REST OF THE MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 123
TABLE 129 REST OF THE MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 123
TABLE 130 GLOBAL HYALURONIC ACID MARKET: COMPANY RANKING 126
TABLE 131 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL HYALURONIC ACID MARKET 128
TABLE 132 PRODUCT APPROVALS & PRODUCT LAUNCHES 129
TABLE 133 JOINT VENTURES & AGREEMENTS 130
TABLE 134 MARKETING STRATEGY 130
TABLE 135 MERGER & ACQUISITION 130
TABLE 136 ALLERGAN PLC: PRODUCTS/SERVICES OFFERED 133
TABLE 137 ALLERGAN: KEY DEVELOPMENTS 134
TABLE 138 CONTIPRO AS: PRODUCTS OFFERED 136
TABLE 139 CONTIPRO AS: KEY DEVELOPMENTS 137
TABLE 140 SYMATESE: PRODUCTS OFFERED 138
TABLE 141 SYMATESE: KEY DEVELOPMENTS 138
TABLE 142 ZHONGLAN INDUSTRY CO., LTD: PRODUCTS OFFERED 140
TABLE 143 ALTERGON ITALIA SRL: PRODUCTS OFFERED 142
TABLE 144 FIDIA FARMACEUTICI SPA: PRODUCTS OFFERED 144
TABLE 145 FIDIA FARMACEUTICI SPA: KEY DEVELOPMENTS 144
TABLE 146 BIOIBERICA SAU: PRODUCTS OFFERED 146
TABLE 147 BIOIBERICA SAU: KEY DEVELOPMENTS 146
TABLE 148 KEWPIE CORPORATION: PRODUCTS OFFERED 149
TABLE 149 SEIKAGAKU CORPORATION: PRODUCTS OFFERED 153
TABLE 150 SEIKAGAKU CORPORATION: KEY DEVELOPMENTS 153
TABLE 151 ANIKA THERAPEUTICS: PRODUCTS/SERVICES OFFERED 157
TABLE 152 ANIKA THERAPEUTICS: KEY DEVELOPMENTS 157

LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS 17
FIGURE 2 HYALURONIC ACID MARKET STRUCTURE 18
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 25
FIGURE 4 MARKET DYNAMICS OVERVIEW 28
FIGURE 5 TRADE DATA FOR SKINCARE PRODUCTS (USD MILLION) 29
FIGURE 6 GROWTH OF THE GLOBAL COSMETICS MARKET (%) 30
FIGURE 7 TOP 5 COUNTRIES FOR COSMETIC PROCEDURES, 2019 31
FIGURE 8 DRIVERS IMPACT ANALYSIS 33
FIGURE 9 RESTRAINT IMPACT ANALYSIS 34
FIGURE 10 SUPPLY CHAIN: GLOBAL HYALURONIC ACID MARKET 36
FIGURE 11 PORTER’S FIVE FORCES ANALYSIS: GLOBAL HYALURONIC ACID MARKET 38
FIGURE 12 GLOBAL HYALURONIC ACID MARKET SHARE, BY GRADE, 2020 (%) 43
FIGURE 13 GLOBAL HYALURONIC ACID MARKET, BY GRADE, 2020 & 2027 (USD MILLION) 44
FIGURE 14 GLOBAL HYALURONIC ACID MARKET SHARE, BY APPLICATION, 2020 (%) 48
FIGURE 15 GLOBAL HYALURONIC ACID MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 48
FIGURE 16 GLOBAL HYALURONIC ACID MARKET SHARE, BY END USER, 2020 (%) 56
FIGURE 17 GLOBAL HYALURONIC ACID MARKET, BY END USER, 2020 & 2027 (USD MILLION) 57
FIGURE 18 GLOBAL HYALURONIC ACID MARKET SHARE, BY REGION, 2020 (%) 63
FIGURE 19 GLOBAL HYALURONIC ACID MARKET, BY REGION, 2020 & 2027 (USD MILLION) 64
FIGURE 20 NORTH AMERICA: HYALURONIC ACID MARKET, BY COUNTRY, 2020 & 2027 65
FIGURE 21 EUROPE: HYALURONIC ACID MARKET, BY COUNTRY, 2020 & 2027 71
FIGURE 22 ASIA-PACIFIC: HYALURONIC ACID MARKET, BY COUNTRY, 2020 & 2027 88
FIGURE 23 LATIN AMERICA: HYALURONIC ACID MARKET, BY COUNTRY, 2020 & 2027 103
FIGURE 24 MIDDLE EAST &AFRICA: HYALURONIC ACID MARKET, BY COUNTRY, 2020 & 2027 112
FIGURE 25 BENCHMARKING OF MAJOR COMPETITORS 125
FIGURE 26 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN GLOBAL HYALURONIC ACID MARKET 127
FIGURE 27 GLOBAL HYALURONIC ACID MARKET, KEY DEVELOPMENTS & GROWTH STRATEGIES (%) 129
FIGURE 28 SALES, 2020 131
FIGURE 29 R&D EXPENDITURE, 2020 131
FIGURE 30 ALLERGAN PLC: FINANCIAL OVERVIEW SNAPSHOT 133
FIGURE 31 ALLERGAN: SWOT ANALYSIS 134
FIGURE 32 CONTIPRO AS: SWOT ANALYSIS 137
FIGURE 33 SYMATESE: SWOT ANALYSIS 139
FIGURE 34 ZHONGLAN INDUSTRY CO., LTD: SWOT ANALYSIS 141
FIGURE 35 ALTERGON ITALIA SRL: SWOT ANALYSIS 143
FIGURE 36 FIDIA FARMACEUTICI SPA: SWOT ANALYSIS 145
FIGURE 37 BIOIBERICA SAU: SWOT ANALYSIS 147
FIGURE 38 KEWPIE CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 148
FIGURE 39 KEWPIE CORPORATION: SWOT ANALYSIS 150
FIGURE 40 SEIKAGAKU CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 152
FIGURE 41 SEIKAGAKU CORPORATION: SWOT ANALYSIS 154
FIGURE 42 ANIKA THERAPEUTICS INC.: FINANCIAL OVERVIEW SNAPSHOT 156
FIGURE 43 ANIKA THERAPEUTICS INC.: SWOT ANALYSIS 158